吸烟与腹腔镜抗反流术后5年反流复发风险无关
结果显示吸烟者与非吸烟者在术后5年症状缓解、质子泵抑制剂停用率及手术满意度上均相似,吸烟未对长期症状学结局产生负面影响。
要点
- 吸烟者与非吸烟者术后5年GERD-HRQL评分及PPI停用率无显著差异。
- 手术满意度在吸烟者与非吸烟者中相似(88% vs. 87%)。
- 无食管裂孔疝患者长期停用PPI的可能性较低(OR 0.23)。
核心结论
- 活跃吸烟未对腹腔镜抗反流手术的长期症状学结局产生负面影响。
主要发现
- 非吸烟者与吸烟者基线PPI使用率(96% vs. 94%,p=0.64)、食管裂孔疝存在率(79% vs. 68%,p=0.13)、食管炎(28% vs. 45%,p=0.13)及DeMeester评分(41.9 vs. 33.6,p=0.47)相似。
- 术后PPI停用率非吸烟者92%、吸烟者94%(p=0.79),GERD-HRQL评分分别降至4[1-7]和5[0-12](p=0.53)。
- 中位随访59[25-74]个月后,GERD-HRQL评分分别为5[2-11]和2[0-13](p=0.61),PPI停用维持率分别为69%和79%(p=0.59)。
- 手术满意度吸烟者88%、非吸烟者87%(p=0.85)。
- 女性性别与术后GERD-HRQL(p<0.01)和GERSS评分(p=0.04)改善显著相关,但长期随访时无此关联;无食管裂孔疝患者长期PPI停用可能性较低(OR 0.23,p<0.01)。
临床怎么用
- 活跃吸烟不应作为腹腔镜抗反流手术的禁忌因素,术后长期症状结局与不吸烟者相当。
局限性
- 回顾性研究设计,吸烟者样本量较小(31例),可能影响统计效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Tobacco use worsens gastrointestinal reflux disease (GERD). Smoking cessation improves GERD symptoms, but its impact on the efficacy of laparoscopic anti-reflux surgery (LARS) is unclear. In this retrospective cohort study, we hypothesized that non-smokers would demonstrate greater long-term improvements in disease-specific quality of life than active smokers. METHODS: Data were maintained in an IRB-approved prospective database, and patients were stratified according to tobacco use. Postoperative follow-up occurred in clinic and long-term follow-up via telephone interview. Outcomes measured were gastroesophageal health-related quality of life (GERD-HRQL) and GERD symptom scale (GERSS) scores, proton pump inhibitor (PPI) cessation, and satisfaction with surgery. RESULTS: Two hundred and thirty-five patients underwent primary LARS, and 31 (13%) were active smokers with 18 median pack-years [10-30]. Baseline PPI use (96% vs. 94%, p = 0.64), presence of a hiatal hernia (79% vs. 68%, p = 0.13), esophagitis (28% vs. 45%, p = 0.13), and DeMeester score (41.9 vs. 33.6, p = 0.47) were similar. Baseline GERD-HRQL and GERSS scores and their post-surgical decreases were also similar between groups. PPI cessation was achieved in 92% of non-smokers and 94% of smokers (p = 0.79), and GERD-HRQL scores decreased to 4 [1-7] and 5 [0-12], respectively (p = 0.53). After 59 [25-74] months, GERD-HRQL scores were 5 [2-11] and 2 [0-13] (p = 0.61) and PPI cessation was maintained in 69% and 79% of patients (p = 0.59). Satisfaction with surgery was similar between smokers and non-smokers (88% vs. 87%, p = 0.85). Female gender was significantly associated with increased improvements in GERD-HRQL (p < 0.01) and GERSS scores (p = 0.04) postoperatively but not at long-term follow-up. Patients without a hiatal hernia were less likely to achieve long-term PPI cessation compared to those with a hernia (OR 0.23, p < 0.01). CONCLUSIONS: After 5 years, smokers demonstrate similar symptom resolution, PPI cessation rates, and satisfaction with surgery as non-smokers. Active smoking does not appear to negatively impact long-term symptomatic outcomes of LARS.
引用
- Wang VL, Jalilvand AD, Gupta A, et al. Tobacco use is not associated with increased risk of recurrent reflux 5 years after laparoscopic anti-reflux surgery. Surg Endosc. 2020. PMID: 32914359. doi:10.1007/s00464-020-07956-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。